GGrantIndex
Sort

261,768 grants matching gene therapy

NHGRI/DIR Bioinformatics and Scientific Programming Core

$3,452,925
Andreas Baxevanis · National Human Genome Research Institute · ZIH · FY2014 · HG

CARDIOVASCULAR GENE THERAPY CENTER

$3,449,355
University Of Pittsburgh At Pittsburgh · U01 · FY2004 · HL

Understanding Papillomavirus Virion Proteins and Vaccines

$3,448,564
John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Childhood Cancer Data Initiative

$3,444,819
Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZID · FY2023 · CA

Retroviral Mediated Gene Transfer Into Primate Hematopoietic Cells

$3,443,414
Robert E Donahue · National Heart, Lung, And Blood Institute · ZIC · FY2016 · HL

Michigan Alzheimer's Disease Research Center

$3,441,683
Henry L Paulson · University Of Michigan At Ann Arbor · P30 · FY2025 · AG

Adult Stem Cells for Therapy of Visual Disorders

$3,441,228
Martin Friedlander · Scripps Research Institute, The · R24 · FY2009 · EY

Novel Inducible Complement C3 Conditional KO Mouse Models to Investigate Neurodegeneration in AD

$3,441,150
Cynthia A Lemere · Brigham And Women'S Hospital · RF1 · FY2018 · AG

INTEGRATED DEVELOPMENT OF NOVEL MOLECULAR MAKERS

$3,441,007
Johns Hopkins University · U01 · FY2001 · CA

Pediatric Brain Tumor ConsortiumA multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors.

$3,440,662
Arzu Onar-Thomas · St. Jude Children'S Research Hospital · UM1 · FY2022 · CA

(1 of 2) Genetic Epidemiology of COPD

$3,440,222
James D Crapo · National Jewish Health · R01 · FY2016 · HL

Michigan Alzheimer's Disease Research Center

$3,437,554
Henry L Paulson · University Of Michigan At Ann Arbor · P30 · FY2024 · AG

THERAPY OF CML

$3,436,780
University Of Texas Md Anderson Can Ctr · P01 · FY2004 · CA

GENERAL CLINICAL RESEARCH CENTER

$3,429,552
Duke University · M01 · FY2002 · RR

A Genomics Based Investigation of the Determinants of Polymicrobial Infectious Disease Outcomes

$3,428,670
David A Rasko · University Of Maryland Baltimore · U19 · FY2022 · AI

SOUTHWEST REGIONAL PRIMATE RESEARCH CENTER

$3,428,186
Southwest Foundation For Biomedical Res · P51 · FY2001 · RR

T-cell receptor gene therapy for cancer

$3,427,390
Christian Hinrichs · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina

$3,425,421
Rachel R. Caspi · National Eye Institute · ZIA · FY2021 · EY

GENERAL CLINICAL RESEARCH CENTER

$3,425,357
New York University School Of Medicine · M01 · FY2002 · RR

Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders

$3,423,644
Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL

Genetic Modification and Novel Cell Therapies in Non-Human Primate Hematopoietic Cells

$3,423,404
So Gun Hong · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL

Women's Interagency HIV Study (WIHS-V)

$3,421,345
Kathryn M Anastos · Albert Einstein College Of Medicine · U01 · FY2014 · AI

Transcriptional Functions of Nuclear Receptors in Cancer Cells

$3,419,333
Trevor K Archer · National Institute Of Environmental Health Sciences · ZIA · FY2012 · ES

Transcriptional Functions of Nuclear Receptors in Cancer Cells

$3,418,430
Trevor K Archer · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES

Diabetes Genome Anatomy Project (DGAP)

$3,417,748
C Ronald Kahn · Joslin Diabetes Center · R01 · FY2006 · DK